| Document |
Document Title |
|
WO/2015/183719A1 |
The invention describes the use of a water-based UV curable inkjet printing ink wherein the ink is basic due to the presence of a tertiary amine, allowing the complete dissolution of an acid functional photoinitiator of Formula I or Form...
|
|
WO/2015/145371A1 |
The present invention relates to a compound of formula I, or an isotopic form, stereoisomer, a tautomer, a pharmaceutically acceptable salt, a solvate, a polymorph, a prodrug, N-oxide or S-oxide thereof; and processes for their preparati...
|
|
WO/2015/129832A1 |
The present invention is a radiosensitive resin composition containing: a polymer having a structural unit that contains the group represented by formula (1); and a radiosensitive acid generator. In formula (1), R1 is a substituted or un...
|
|
WO/2015/125572A1 |
A method for producing a thiopyranose compound represented by formula (2), which comprises reacting a compound represented by formula (1) with a sulfur compound. X represents a leaving group; A represents an oxygen atom or a sulfur atom;...
|
|
WO/2015/083663A1 |
A purpose of the present invention is to provide a polymerizable monomer having low contamination with respect to liquid crystals, high sensitivity to light of long wavelengths, and an exceptional sensitizing effect, and a polymer compou...
|
|
WO/2015/076395A1 |
The present invention addresses the problem of providing: an acid- and radical-generating agent which has high sensitivity to an active energy ray having a wavelength of about 300 to 450 nm, can exhibit both high acid-generating ability ...
|
|
WO/2015/062935A1 |
A process for the preparation of optionally asymmetric acetal compounds, comprising reacting a compound containing a hydroxyl group with a vinylether compound in the presence of a zwitterionic catalyst including at least one basic nitrog...
|
|
WO/2015/044229A1 |
The invention relates to new PI3K/AKT/m TOR inhibitors and their use for the prevention and/or the treatment of a disease selected from the group consisting of: inflammatory diseases, autoimmune diseases, neurodegenerative diseases, canc...
|
|
WO/2015/032069A1 |
Provided is a photo-initiator of formula (I), wherein PI is a photo-initiator group containing an aromatic ring capable of initiating a free-radical polymerization reaction when being exposed to actinic radiation, and is connected to Y t...
|
|
WO/2015/032942A1 |
The invention relates to a compound of Formula (I) and its use as a selective dipeptidyl peptidase I inhibitor, as well as pharmaceutical compositions comprising said compound, and methods of treatment involving said compounds.
|
|
WO/2015/030189A1 |
Provided is a compound which exhibits bone formation acceleration activity (and/or bone resorption suppression activity). The compound is either a compound having a general formula (I) (wherein the substituents are as defined in the desc...
|
|
WO/2015/002230A1 |
The present invention relates to compounds (I), which have RORγt inhibitory effects, and salts thereof. In formula (I), each notation is as described in the Specification. (I)
|
|
WO/2014/185303A1 |
Provided are: a base amplifier that can be used in the cross-linking reaction of an epoxy compound or the like, that is capable of generating a new base as a result of the presence of a base, that is highly soluble with respect to organi...
|
|
WO/2014/160339A1 |
Compounds are provided that can exhibit anti-cancer and/or anti-inflammatory properties, in some aspects, methods of treating an inflammatory disease or a hyperproliferative disease, such as cancer, with the compounds are provided.
|
|
WO/2014/160649A1 |
This invention pertains generally to antibacterial organic compounds of Formula I as described herein, and pharmaceutical compositions containing such compounds. In certain aspects, the invention pertains to treating infections caused by...
|
|
WO/2014/125231A1 |
The invention relates to a method for the synthesis of 4-(heterocycloalkyl)-benzene-1,3-diol compounds of general formulae (I) and (III) wherein X can be an oxygen atom or a sulphur atom. The invention also relates to a method for the sy...
|
|
WO/2014/111113A1 |
The present invention relates to compounds of formula (I) and, in particular, drugs containing at least one compound of formula I for use in the treatment and/or prophylaxis of physiological and/or pathophysiological states, in the cause...
|
|
WO/2014/094544A1 |
Provided are a phenyl C-glucoside derivative containing a deoxyglucose structure as represented by formula I, preparation method thereof, pharmaceutical composition containing same, and uses thereof in the preparation of drugs for treati...
|
|
WO/2014/098015A1 |
Provided are a 1-aryl-1-heterodiene compound represented by formula (I) or a salt thereof, and a pesticide containing said compound or salt thereof as an active ingredient. In formula (I), Q represents an aryl ring or the like; D2 repres...
|
|
WO/2014/071836A1 |
Disclosed is a 9H-thioxanthen-9-one oxide derivative, having a structural formula as represented by formula (1), (2), (3) or (4); in formulas (1) and (2), R1, R2, R3, R4, R5, R6, R7, and R8 are respectively selected from one of hydrogen ...
|
|
WO/2014/031784A1 |
Disclosed herein are new antiviral compounds, together with pharmaceutical compositions that include one or more antiviral compounds, and methods of synthesizing the same. Also disclosed herein are methods of ameliorating and/or treating...
|
|
WO/2014/031755A1 |
Disclosed herein are novel derivatives of fendiline, including compounds of the formula: wherein the variables are defined herein. Also provided are pharmaceutical compositions, kits and articles of manufacture comprising these derivativ...
|
|
WO/2014/025370A1 |
A method of quenching excited state energy from a photodegradable pigment that has been excited by absorption of light having a wavelength in the wavelength range of 290 - 800 nm, comprising reacting a pigment with a conjugated fused tri...
|
|
WO/2014/018859A1 |
The invention provides potent inhibitors of small molecule inhibitors of Krüppel-like factor 5 (KLF5) expression. Compounds of the invention are small molecule inhibitors of KLF5 expression which can be effective delay or prevent colon ...
|
|
WO/2014/009194A1 |
A polymerizable thioxanthone according to Formula (I) wherein, A represents a thioxanthone moiety; R1 and R2 are independently selected from the group consisting of a hydrogen, an alkyl group, an aikenyl group, an alkynyl group, an aryl ...
|
|
WO/2013/170859A2 |
The present invention provides polymeric photoinitiators being co-polymers of photoinitiator monomers and at least one further monomer, as well as the photoinitiator monomers being intermediates in the preparation of such polymeric photo...
|
|
WO/2013/159224A1 |
Certain 2-carbamo(thio)yl-1,3-dioxopropyl derivatives, or the tautomers and pharmacologically acceptable addition salts thereof are found to be toxic to cancer cells, in part, by inhibiting DNA topoisomerase II enzyme making them candida...
|
|
WO/2013/161816A1 |
The present invention provides a compound represented by general formula (I) [wherein each symbol is as defined in the description], which has an excellent peripheral blood lymphocyte-reducing activity and is useful for the treatment or ...
|
|
WO/2013/157528A1 |
Provided is a medicinal agent comprising a compound represented by general formula (1), a pharmaceutically acceptable salt of the compound or a solvate of the compound or the pharmaceutically acceptable salt. A compound represented by ge...
|
|
WO/2013/128378A1 |
The present invention relates to phenyl alkanoic acid derivatives (the compounds of Formula (I)); and their isotopic forms, stereoisomeric and tautomeric forms and mixtures thereof in all ratios, or pharmaceutically acceptable salts, pha...
|
|
WO/2013/118907A1 |
An amide compound represented by formula (I) has an excellent pest control effect. (In the formula, Y represents a 3-7 membered saturated heterocyclic ring which contains, as ring-forming component(s), one or more atoms or groups that ar...
|
|
WO/2013/060653A1 |
This invention relates to novel 1-cycloalkyl- or l-heterocyclyl-hydroxyimino-3-phen propanes of the formula wherein R1 to R7 are as defined in the description and in the claims, as well as pharmaceutically acceptable salts thereof. These...
|
|
WO/2012/136120A1 |
An aryl acrylamide compound, or a geometric isomer thereof, or a pharmaceutically acceptable salt or hydrate thereof as represented by Formula I, a preparation method therefor, and a pharmaceutical composition containing the compound. Th...
|
|
WO/2012/107262A1 |
New dihydrobenzopyran, thiochroman, tetrahydroquinoleine and tetrahydronaphthalene derivatives and their use in anti-cancer therapy with the general formula (I).
|
|
WO/2012/102355A1 |
The purpose of the present invention is to provide a compound having a potent activity of decreasing an intraocular pressure and having no adverse side effect on eyes, such as the irritation to eyes and the increase in aqueous humor prot...
|
|
WO/2012/077720A1 |
To provide: a compound, which is suitable for a sealing agent for electronic components or the like, especially suitable for a liquid crystal sealing agent and does not easily generate out gas, and which can be used for a photopolymeriza...
|
|
WO/2012/072489A1 |
The invention relates to novel alpha,beta-unsaturated imines, to a method for producing same, to the use thereof for combating animal pests, including anthropods and in particular insects, and to the use thereof in vector control.
|
|
WO/2012/070024A1 |
Compositions for the treatment of cancer comprising coumarin and thiocoumarin derivatives of Formulas I- XII are disclosed. Said derivatives preferentially inhibit carbonic anhydrase IX and XII (which are associated with hypoxic and meta...
|
|
WO/2012/062041A1 |
Disclosed are aromatic ketone compounds with para- or meso-substituted multifunctional groups as represented by the general formulae I-III, preparation methods thereof, and free-radical polymerization photoinitiators comprising the compo...
|
|
WO/2012/062692A1 |
3-Esters and 3-amides of thioxanthone bearing alkyl chains of appropriate length and can be used as photoinitiators or sensitizers in photopolymerizable systems, in particular for the preparation of coatings compatible with the food use.
|
|
WO/2012/063751A1 |
Provided is an organic light emitting element having a high light emission efficiency and a low drive voltage. In the organic light emitting element including a positive electrode, a negative electrode and an organic compound layer dispo...
|
|
WO/2012/062332A2 |
The present invention provides novel photoinitiators for polyurethane formation, in which a photoinitiator moiety and a tertiary amine are incorporated into the photoinitiator structure, and thus the polyurethane polymer.
|
|
WO/2012/052288A1 |
A polymerisable photoinitiator according to Formula (I): wherein: R1 and R2 are independently selected from the group consisting of hydrogen, a substituted or unsubstituted alkyl group, a substituted or unsubstituted alkenyl group, a sub...
|
|
WO/2012/029758A1 |
The purpose of the present invention is to provide a photosensitive resin composition having high photosensitivity, excellent transparency in a cured film, and wide developing tolerance, and to provide a method for forming a cured film u...
|
|
WO/2012/003644A1 |
Thioxanthone-4-carboxylates, their preparation methods, photoinitiator compositions and uses thereof are disclosed. The compounds with the following structure of formula (I) are disclosed, in which R1 is selected from hydrogen, halo, C1-...
|
|
WO/2012/000608A2 |
The present invention relates to novel beta-aminoaldehyde derivatives of the formulae (I), (II) and (III), in which the substituents R1 to R5 and A have the meaning given in the description, to a novel process for their preparation, to i...
|
|
WO/2011/101704A1 |
Disclosed herein is an improved process for the preparation of (4S,6S)-4-(ethylamino)-5,6-dihydro-6-methyl-4H-thieno-[2,3-b
]thiopyran-2-sulfonamide-7,7- dioxide (Dorzolamide) and its intermediates.
|
|
WO/2011/083264A1 |
The invention relates to compounds of formula (I), where R1, R2, R3 and R4, identical or different, each represent a hydrogen atom, a halogen atom or a cyano, hydroxyl, thio, nitro, alkyl, aryl, alkoxy, aryloxy, alkylthio, arylthio, carb...
|
|
WO/2011/068569A1 |
The present invention relates to fluorescent dyes in general. The present invention provides a wide range of fluorescent dyes and kits containing the same, which are applicable for labeling a variety of biomolecules, cells and microorgan...
|
|
WO/2011/069118A1 |
Compounds of structure (I): including stereoisomers and pharmaceutically acceptable salts thereof, wherein X, R1, R2, R3, R4, R5, R6 and R7 are as defined herein. Such compounds have activity as SHIP1 modulators, and thus may be used to ...
|
